Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Characteristics of multiple nodules in a patient with pulmonary Langerhans cell histiocytosis: A case report.

Kanaji N, Tokunaga Y, Ishikawa R, Watanabe N, Kadowaki N.

World J Clin Cases. 2019 Sep 6;7(17):2519-2525. doi: 10.12998/wjcc.v7.i17.2519.

2.

Association of specific metastatic organs with the prognosis and chemotherapeutic response in patients with advanced lung cancer.

Kanaji N, Tadokoro A, Watanabe N, Inoue T, Kadowaki N, Ishii T.

Respir Investig. 2019 Sep;57(5):472-480. doi: 10.1016/j.resinv.2019.06.004. Epub 2019 Jul 18.

PMID:
31327681
3.

Asthma mortality based on death certificates: A demographic survey in Kagawa, Japan.

Kamei T, Kanaji N, Nakamura H, Arakawa Y, Miyawaki H, Kishimoto N, Suzaki N, Yamamoto A, Nanki N, Yamazaki Y, Ishii T, Kohi F, Hirao T, Fujita J, Bandoh S, Hoshikawa Y.

Respir Investig. 2019 May;57(3):268-273. doi: 10.1016/j.resinv.2019.02.002. Epub 2019 Mar 1.

PMID:
30833156
4.

The usefulness of pleural fluid presepsin, C-reactive protein, and procalcitonin in distinguishing different causes of pleural effusions.

Watanabe N, Ishii T, Kita N, Kanaji N, Nakamura H, Nanki N, Ueda Y, Tojo Y, Kadowaki N, Bandoh S.

BMC Pulm Med. 2018 Nov 23;18(1):176. doi: 10.1186/s12890-018-0740-3.

5.

Pulmonary Multiloculated 'Lotus Torus-like' Sarcoidosis Mimicking Lung Adenocarcinoma.

Kanaji N, Nakashima N, Inoue T, Ibuki E, Murota M, Kadowaki N.

Intern Med. 2019 Feb 1;58(3):419-422. doi: 10.2169/internalmedicine.1541-18. Epub 2018 Sep 12.

6.

Clinical features of patients with lung cancer accompanied by thromboembolism or disseminated intravascular coagulation.

Kanaji N, Mizoguchi H, Inoue T, Tadokoro A, Watanabe N, Ishii T, Tojo Y, Yamaguchi M, Kadowaki N.

Ther Clin Risk Manag. 2018 Aug 1;14:1361-1368. doi: 10.2147/TCRM.S164700. eCollection 2018.

7.

Subacute Sensorimotor Neuropathy Accompanied by Anti-ganglioside GM1 Antibody in a Patient with Lung Cancer.

Kanaji N, Kume K, Mizoguchi H, Inoue T, Watanabe N, Nishiyama N, Kadowaki N, Ishii T.

Intern Med. 2018 Nov 15;57(22):3289-3292. doi: 10.2169/internalmedicine.0667-17. Epub 2018 Jul 6.

8.

Transforming Growth Factor-Beta Produced by Non-small Cell Lung Cancer Cells Contributes to Lung Fibroblast Contractile Phenotype.

Kanaji N, Yokohira M, Watanabe N, Kadowaki N, Bandoh S.

Anticancer Res. 2018 Apr;38(4):2007-2014.

PMID:
29599317
9.

Additive antitumour effect of D‑allose in combination with cisplatin in non-small cell lung cancer cells.

Kanaji N, Kamitori K, Hossain A, Noguchi C, Katagi A, Kadowaki N, Tokuda M.

Oncol Rep. 2018 Mar;39(3):1292-1298. doi: 10.3892/or.2018.6192. Epub 2018 Jan 4.

PMID:
29328484
10.

Peripheral-type small cell lung cancer is associated with better survival and higher frequency of interstitial lung disease.

Kanaji N, Sakai K, Ueda Y, Miyawaki H, Ishii T, Watanabe N, Kita N, Kadota K, Kadowaki N, Bandoh S.

Lung Cancer. 2017 Jun;108:126-133. doi: 10.1016/j.lungcan.2017.03.013. Epub 2017 Mar 27.

PMID:
28625624
11.

Hepatocyte growth factor produced in lung fibroblasts enhances non-small cell lung cancer cell survival and tumor progression.

Kanaji N, Yokohira M, Nakano-Narusawa Y, Watanabe N, Imaida K, Kadowaki N, Bandoh S.

Respir Res. 2017 Jun 15;18(1):118. doi: 10.1186/s12931-017-0604-z.

12.
13.

A Grading System Combining Tumor Budding and Nuclear Diameter Predicts Prognosis in Resected Lung Squamous Cell Carcinoma.

Kadota K, Miyai Y, Katsuki N, Kushida Y, Matsunaga T, Okuda M, Yokomise H, Kanaji N, Bandoh S, Haba R.

Am J Surg Pathol. 2017 Jun;41(6):750-760. doi: 10.1097/PAS.0000000000000826.

PMID:
28248819
14.

Phanerochaete sordida as a cause of pulmonary nodule in an immunocompromised patient: a case report.

Watanabe N, Ohkusu K, Okuda M, Imataki O, Ishii T, Negayama K, Tadokoro A, Kita N, Takagi T, Kanaji N, Kadowaki N, Bandoh S.

BMC Infect Dis. 2017 Feb 10;17(1):135. doi: 10.1186/s12879-017-2244-9.

15.

An autopsy case of bronchiolitis obliterans as a previously unrecognized adverse event of afatinib treatment.

Kanaji N, Chiba Y, Sato A, Ueno M, Tadokoro A, Kita N, Ishii T, Watanabe N, Kadowaki N, Bandoh S.

Respir Investig. 2017 Jan;55(1):58-62. doi: 10.1016/j.resinv.2016.09.002. Epub 2016 Oct 27.

PMID:
28012496
16.

Impact of idiopathic pulmonary fibrosis on advanced non-small cell lung cancer survival.

Kanaji N, Tadokoro A, Kita N, Murota M, Ishii T, Takagi T, Watanabe N, Tojo Y, Harada S, Hasui Y, Kadowaki N, Bandoh S.

J Cancer Res Clin Oncol. 2016 Aug;142(8):1855-65. doi: 10.1007/s00432-016-2199-z. Epub 2016 Jun 27.

17.

An Uncharted Constellation: TAFRO Syndrome.

Tadokoro A, Kanaji N, Hara T, Matsumoto K, Ishii T, Takagi T, Watanabe N, Kita N, Kawauchi M, Ueno M, Kadowaki N, Bandoh S.

Am J Med. 2016 Sep;129(9):938-41. doi: 10.1016/j.amjmed.2016.05.010. Epub 2016 Jun 4. No abstract available.

PMID:
27267287
18.

Nuclear grade based on transbronchial cytology is an independent prognostic factor in patients with advanced, unresectable non-small cell lung cancer.

Kadota K, Miyai Y, Katsuki N, Kushida Y, Matsunaga T, Okuda M, Yokomise H, Kanaji N, Bandoh S, Haba R.

Cancer Cytopathol. 2016 Sep;124(9):630-40. doi: 10.1002/cncy.21736. Epub 2016 May 13.

19.

Confluence-dependent resistance to cisplatin in lung cancer cells is regulated by transforming growth factor-beta.

Yokokura S, Kanaji N, Tadokoro A, Yokokura S, Kadowaki N, Bandoh S.

Exp Lung Res. 2016 May;42(4):175-81. doi: 10.3109/01902148.2016.1172370. Epub 2016 Apr 26.

PMID:
27116015
20.

Vimentin Regulates Invasiveness and Is a Poor Prognostic Marker in Non-small Cell Lung Cancer.

Tadokoro A, Kanaji N, Liu D, Yokomise H, Haba R, Ishii T, Takagi T, Watanabe N, Kita N, Kadowaki N, Bandoh S.

Anticancer Res. 2016 Apr;36(4):1545-51.

PMID:
27069130
21.

Air-leak Syndrome by Pleuroparenchymal Fibroelastosis after Bone Marrow Transplantation.

Ishii T, Bandoh S, Kanaji N, Tadokoro A, Watanabe N, Imataki O, Dobashi H, Kushida Y, Haba R, Yokomise H.

Intern Med. 2016;55(2):105-11. doi: 10.2169/internalmedicine.55.4539. Epub 2016 Jan 15.

22.

Transbronchial Dissemination of Squamous Cell Lung Cancer.

Tadokoro A, Kanaji N, Ishii T, Watanabe N, Inoue T, Kadowaki N, Bandoh S.

Clin Med Insights Oncol. 2015 Dec 8;9:129-33. doi: 10.4137/CMO.S32707. eCollection 2015.

23.

An Autopsy Case of Rapidly Progressing Spindle Cell Carcinoma of the Lung Accompanied with Intratumor Hemorrhage.

Kida J, Kanaji N, Kishi S, Imaida K, Bandoh S.

Am J Case Rep. 2015 Nov 12;16:805-10.

24.

Squamous Cell Lung Cancer Associated With Systemic Sclerosis.

Kanaji N, Okuda M, Dobashi H, Kameda T, Tadokoro A, Wakiya R, Kadowaki N, Bandoh S.

J Clin Med Res. 2015 Nov;7(11):896-900. doi: 10.14740/jocmr2313w. Epub 2015 Sep 25.

25.

Prostaglandin E2 switches from a stimulator to an inhibitor of cell migration after epithelial-to-mesenchymal transition.

Li YJ, Kanaji N, Wang XQ, Sato T, Nakanishi M, Kim M, Michalski J, Nelson AJ, Farid M, Basma H, Patil A, Toews ML, Liu X, Rennard SI.

Prostaglandins Other Lipid Mediat. 2015 Jan-Mar;116-117:1-9. doi: 10.1016/j.prostaglandins.2014.10.003. Epub 2014 Oct 31.

PMID:
25460827
26.

Anaplastic lymphoma kinase gene analysis as a useful tool for identifying primary unknown metastatic lung adenocarcinoma.

Watanabe N, Ishii T, Takahama T, Tadokoro A, Kanaji N, Dobashi H, Bandoh S.

Intern Med. 2014;53(23):2711-5. Epub 2014 Dec 1.

27.

Increases in serum CYFRA21-1 concentration during successful treatment with crizotinib.

Kanaji N, Tadokoro A, Watanabe N, Inoue T, Ishii T, Dobashi H, Bandoh S.

Am J Case Rep. 2014 Nov 3;15:480-4. doi: 10.12659/AJCR.891194.

28.

Higher susceptibility of NOD/LtSz-scid Il2rg (-/-) NSG mice to xenotransplanted lung cancer cell lines.

Kanaji N, Tadokoro A, Susaki K, Yokokura S, Ohmichi K, Haba R, Watanabe N, Bandoh S, Ishii T, Dobashi H, Matsunaga T.

Cancer Manag Res. 2014 Oct 21;6:431-6. doi: 10.2147/CMAR.S71185. eCollection 2014.

29.

Paraneoplastic syndromes associated with lung cancer.

Kanaji N, Watanabe N, Kita N, Bandoh S, Tadokoro A, Ishii T, Dobashi H, Matsunaga T.

World J Clin Oncol. 2014 Aug 10;5(3):197-223. doi: 10.5306/wjco.v5.i3.197. Review.

30.

Fibroblasts that resist cigarette smoke-induced senescence acquire profibrotic phenotypes.

Kanaji N, Basma H, Nelson A, Farid M, Sato T, Nakanishi M, Wang X, Michalski J, Li Y, Gunji Y, Feghali-Bostwick C, Liu X, Rennard SI.

Am J Physiol Lung Cell Mol Physiol. 2014 Sep 1;307(5):L364-73. doi: 10.1152/ajplung.00041.2014. Epub 2014 Jul 11.

31.

Esophageal anthracosis with tuberculous lymphadenitis confirmed on transesophageal endoscopic ultrasound-guided fine-needle aspiration.

Nishiyama N, Mori H, Kobara H, Rafiq K, Fujihara S, Katou K, Aritomo Y, Ono M, Kamada H, Oryu M, Kanaji N, Masaki T.

Intern Med. 2014;53(6):577-80.

32.

Membranous glomerulonephritis associated with Mycobacterium shimoidei pulmonary infection.

Kanaji N, Kushida Y, Bandoh S, Ishii T, Haba R, Tadokoro A, Watanabe N, Takahama T, Kita N, Dobashi H, Matsunaga T.

Am J Case Rep. 2013 Dec 16;14:543-7. doi: 10.12659/AJCR.889684. eCollection 2013.

33.

Anti-inflammatory effects of budesonide in human lung fibroblast are independent of histone deacetylase 2.

Wang X, Nelson A, Weiler ZM, Patil A, Sato T, Kanaji N, Nakanishi M, Michalski J, Farid M, Basma H, Levan TD, Miller-Larsson A, Wieslander E, Muller KC, Holz O, Magnussen H, Rabe KF, Liu X, Rennard SI.

J Inflamm Res. 2013 Aug 20;6:109-19. doi: 10.2147/JIR.S43736. eCollection 2013.

34.

Paraneoplastic focal segmental glomerulosclerosis in a patient with lung adenocarcinoma.

Tadokoro A, Ishii T, Takahama T, Watanabe N, Takano K, Kanaji N, Imataki O, Dobashi H, Bandoh S, Matsunaga T.

Intern Med. 2013;52(17):1953-6.

35.

Smad3 mediates cigarette smoke extract (CSE) induction of VEGF release by human fetal lung fibroblasts.

Farid M, Kanaji N, Nakanishi M, Gunji Y, Michalski J, Iwasawa S, Ikari J, Wang X, Basma H, Nelson AJ, Liu X, Rennard SI.

Toxicol Lett. 2013 Jul 4;220(2):126-34. doi: 10.1016/j.toxlet.2013.04.011. Epub 2013 Apr 22.

PMID:
23618901
36.

Differential roles of JNK, ERK1/2, and p38 mitogen-activated protein kinases on endothelial cell tissue repair functions in response to tumor necrosis factor-α.

Kanaji N, Nelson A, Wang X, Sato T, Nakanishi M, Gunji Y, Basma H, Michalski J, Farid M, Rennard SI, Liu X.

J Vasc Res. 2013;50(2):145-56. doi: 10.1159/000345525. Epub 2012 Dec 18.

PMID:
23258237
37.

Attenuation of inhibitory prostaglandin E2 signaling in human lung fibroblasts is mediated by phosphodiesterase 4.

Michalski J, Kanaji N, Liu X, Nogel S, Wang X, Basma H, Nakanishi M, Sato T, Gunji Y, Fahrid M, Nelson A, Muller KC, Holz O, Magnussen H, Rabe KF, Toews ML, Rennard SI.

Am J Respir Cell Mol Biol. 2012 Dec;47(6):729-37. doi: 10.1165/rcmb.2012-0057OC. Epub 2012 Oct 4.

38.

Potentiated activation of VLA-4 and VLA-5 accelerates proplatelet-like formation.

Matsunaga T, Fukai F, Kameda T, Shide K, Shimoda H, Torii E, Kamiunten A, Sekine M, Yamamoto S, Hidaka T, Kubuki Y, Yokokura S, Uemura M, Matsuoka A, Waki F, Matsumoto K, Kanaji N, Ishii T, Imataki O, Dobashi H, Bandoh S, Shimoda K.

Ann Hematol. 2012 Oct;91(10):1633-43. doi: 10.1007/s00277-012-1498-y. Epub 2012 May 29.

PMID:
22644786
39.

Detection of EML4-ALK fusion genes in a few cancer cells from transbronchial cytological specimens utilizing immediate cytology during bronchoscopy.

Kanaji N, Bandoh S, Ishii T, Tadokoro A, Watanabe N, Takahama T, Haba R, Imataki O, Dobashi H, Matsunaga T.

Lung Cancer. 2012 Aug;77(2):293-8. doi: 10.1016/j.lungcan.2012.03.018. Epub 2012 Apr 10.

PMID:
22494566
40.

Prostaglandin E2 stimulates the production of vascular endothelial growth factor through the E-prostanoid-2 receptor in cultured human lung fibroblasts.

Nakanishi M, Sato T, Li Y, Nelson AJ, Farid M, Michalski J, Kanaji N, Wang X, Basma H, Patil A, Goraya J, Liu X, Togo S, L Toews M, Holz O, Muller KC, Magnussen H, Rennard SI.

Am J Respir Cell Mol Biol. 2012 Feb;46(2):217-23. doi: 10.1165/rcmb.2010-0115OC.

41.

The p38 mitogen-activated protein kinases modulate endothelial cell survival and tissue repair.

Kanaji N, Nelson A, Allen-Gipson DS, Sato T, Nakanishi M, Wang X, Li Y, Basma H, Michalski J, Farid M, Rennard SI, Liu X.

Inflamm Res. 2012 Mar;61(3):233-44. doi: 10.1007/s00011-011-0405-7. Epub 2011 Dec 3.

PMID:
22138711
42.

Detection of epidermal growth factor receptor mutations in a few cancer cells from transbronchial cytologic specimens by reverse transcriptase-polymerase chain reaction.

Kanaji N, Bandoh S, Ishii T, Kushida Y, Haba R, Kohno K, Dobashi H, Ohnishi H, Matsunaga T.

Mol Diagn Ther. 2011 Dec 1;15(6):353-9. doi: 10.2165/11595700-000000000-00000.

PMID:
22117119
43.

Inflammatory cytokines regulate endothelial cell survival and tissue repair functions via NF-κB signaling.

Kanaji N, Sato T, Nelson A, Wang X, Li Y, Kim M, Nakanishi M, Basma H, Michalski J, Farid M, Chandler M, Pease W, Patil A, Rennard SI, Liu X.

J Inflamm Res. 2011;4:127-38. doi: 10.2147/JIR.S19461. Epub 2011 Sep 15.

44.

Cytokeratins negatively regulate the invasive potential of lung cancer cell lines.

Kanaji N, Bandoh S, Ishii T, Fujita J, Ishida T, Matsunaga T, Kubo A.

Oncol Rep. 2011 Oct;26(4):763-8. doi: 10.3892/or.2011.1357. Epub 2011 Jun 23.

PMID:
21701782
45.

IL-4 induces differentiation of human embryonic stem cells into fibrogenic fibroblast-like cells.

Sato T, Liu X, Basma H, Togo S, Sugiura H, Nelson A, Nakanishi M, Kanaji N, Wang X, Kim M, Li Y, Michalski J, Farid M, Sharp JG, Rennard SI.

J Allergy Clin Immunol. 2011 Jun;127(6):1595-603.e9. doi: 10.1016/j.jaci.2011.01.049. Epub 2011 Mar 8.

46.

Reduced miR-146a increases prostaglandin E₂in chronic obstructive pulmonary disease fibroblasts.

Sato T, Liu X, Nelson A, Nakanishi M, Kanaji N, Wang X, Kim M, Li Y, Sun J, Michalski J, Patil A, Basma H, Holz O, Magnussen H, Rennard SI.

Am J Respir Crit Care Med. 2010 Oct 15;182(8):1020-9. doi: 10.1164/rccm.201001-0055OC. Epub 2010 Jun 3.

47.

Prostaglandin E₂ inhibits human lung fibroblast chemotaxis through disparate actions on different E-prostanoid receptors.

Li YJ, Wang XQ, Sato T, Kanaji N, Nakanishi M, Kim M, Michalski J, Nelson AJ, Sun JH, Farid M, Basma H, Patil A, Toews ML, Liu X, Rennard SI.

Am J Respir Cell Mol Biol. 2011 Jan;44(1):99-107. doi: 10.1165/rcmb.2009-0163OC. Epub 2010 Mar 4.

48.

MicroRNA-146a modulates human bronchial epithelial cell survival in response to the cytokine-induced apoptosis.

Liu X, Nelson A, Wang X, Kanaji N, Kim M, Sato T, Nakanishi M, Li Y, Sun J, Michalski J, Patil A, Basma H, Rennard SI.

Biochem Biophys Res Commun. 2009 Feb 27;380(1):177-82. doi: 10.1016/j.bbrc.2009.01.066. Epub 2009 Jan 22.

PMID:
19167348
49.

3'-Deoxy-3'-18F-fluorothymidine as a proliferation imaging tracer for diagnosis of lung tumors: comparison with 2-deoxy-2-18f-fluoro-D-glucose.

Yamamoto Y, Nishiyama Y, Ishikawa S, Gotoh M, Bandoh S, Kanaji N, Asakura M, Ohkawa M.

J Comput Assist Tomogr. 2008 May-Jun;32(3):432-7. doi: 10.1097/RCT.0b013e3180980db9.

PMID:
18520552
50.

Full-length cytokeratin 8 is released and circulates in patients with non-small cell lung cancer.

Ishii T, Bandoh S, Fujita J, Ohtsuki Y, Tojo Y, Kanaji N, Fukunaga Y, Ueda Y, Ishida T, Kubo A.

Tumour Biol. 2008;29(1):57-62. doi: 10.1159/000132572. Epub 2008 May 23.

PMID:
18497550

Supplemental Content

Loading ...
Support Center